Navigation Links
Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
Date:4/25/2008

s Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
2. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
3. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
4. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
5. Medarex to Present at the JPMorgan Small/Mid Cap Conference
6. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
7. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
8. Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
9. Bristol-Myers Squibb to Present at Healthcare Conferences
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
(Date:11/25/2009)...C sees few signs of trouble with the H1N1 vaccine,...) -- The ongoing H1N1 swine flu pandemic may be dr... younger patients, a U.S. health official said Wed... pneumococcal infections around the country," Dr. ... Immunization and Respiratory Diseases at the U.S....
(Date:11/25/2009)...ancer vaccine carried into the body on a carefully... to successfully eliminate tumors in mammals, scie...anslational Medicine . , The new approach, pione...University, uses plastic disks impregnated with tu... to reprogram the mammalian immune system to attac...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...e the risk of developing potentially harmful blood... center reported a case of 25 year old healthy mal... known as subdural haematomas, after riding severa...ath. It usually occurs in older men who are alcoho...
...rst forms of nightmare over the past 3 weeks , now...hreat of malaria . Malaria , not a new diseas...eas of Munger, 200 km (125 miles) southeast of the...te's health minister Mr.Shakuni Choudhary. Mr...
...itis, often grouped together under inflammatory bo...trialized nations with stringent standards of publ...ment prevents the human immune system from interac...tment regimen of worms may help patients with Croh...
...ed form of epidemic fevers, is spread by a virulen...ave 12 deaths (in the past fortnight) from leptosp...es in city hospitals, " Maharashtra state Health M... the patients come to public hospitals when their ...
...therapeutic challenge for many practising allopath...ine has taken its stride. Acupuncture vs massage f... practitioners. Dr. Dominik Irnich of Ludwig-Ma... in the short term. In his research which inclu...
...o autoimmune destruction of the pancreatic islet c... no longer produces insulin and and there is a rai...s type I Diabetes develop are at a higher risk to ...id a study involving 57 diabetics ages 12 to 21 an...
Other Medicine News:Health News:WORM! WORM! all the way 2
(Date:11/25/2009)...-FirstCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOne...llyintegratedpharmaceuticalcompanydevelopingandpro...fChina("PRC"),today,announcedthattheCompanyrecentl...PharmaceuticalandBiologicalProducts("ICPBP")examin...manProstateSpecific,Antigen(ColloidalGold)anditsDe...
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...l/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecom...ivesurgicaltreatmentsforthespine,announcedtodaytha...,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocu...ny,sproductsandwillincludecommentsfrommanagementfo...umbersare1-877-407-4018fordomesticcallersand1-201-...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 1ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 2ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 3IBM Scientists First to Image the Anatomy of a Molecule 4913 1IBM Scientists First to Image the Anatomy of a Molecule 4913 2IBM Scientists First to Image the Anatomy of a Molecule 4913 3IBM Scientists First to Image the Anatomy of a Molecule 4913 4IBM Scientists First to Image the Anatomy of a Molecule 4913 5Los Angeles Clinic 28laserandveinclinic com 29 Offers the Latest Laser Skin Rejuvenation Treatments 55581 1Los Angeles Clinic 28laserandveinclinic com 29 Offers the Latest Laser Skin Rejuvenation Treatments 55581 2
... Benefit Demonstrated for an AI Over Tamoxifen in,...Analysis of the entire,population of a single tria...ancer can be significantly improved by switching f...is of the,Arimidex,-,Nolvadex 95, (ARNO 95) study...logy, confirms that postmenopausal women,who have ...
...ss.--(BUSINESS WIRE)--Jun 18, 2007 - Novelos,Thera...ompany,focused on the development of therapeutics ...ouraging results in an ongoing,Dana-Farber/Partner... combination with carboplatin in platinum-resistan...re evaluable for best,overall tumor response (asse...
Other Medicine Technology:Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 3
Snap-In Snap-Out®-II Mini 90º Dissecting Forceps Insert
Optima III Noninsulated Strong Forceps, without ratchet
Snap-In Snap-Out®-II Python Grasping Forceps Insert
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Medicine Products: